← Leaderboards
Malcolm V Brock
Johns Hopkins University
$1,716,555
Attributed
$2,945,428
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $530.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,945,428 · 4
By mechanism
R01$1,462,965 · 1
UH3$994,782 · 1
K23$419,510 · 1
M01$68,171 · 1
Top collaborators
- Frank Gert Werner Bosmans3 shared
- Yuping Mei3 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Xinzhong Dong$16,603,888
- John T. Walkup$13,819,292
- Pamela J Surkan$5,772,166
- Liang Han$3,825,211
- Elizabeth Nesoff$3,192,732
Others in their field
Top investigators on “Reporting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$564,567,727
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Bambra Strokes · Ppd Development Lp$461,655,950
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ReportingPlayMalignant Neoplasm Of LungX-Ray Computed TomographyResearch PersonnelCohortBiological MarkersSpecimenBiologicalBiopsySamplingSmokerTissuesBenignMalignant NeoplasmsEnrollmentDiagnosisLung NoduleClinical ResearchChestMalignant - DescriptorAutosomeAutonomic Nervous SystemAmino Acid Substitution
Grant awards (10)
Sodium channel mutations as a possible cause for primary dysautonomia$439,639
R01 · FY2025 · NS · contact PI
Sodium channel mutations as a possible cause for primary dysautonomia$492,528
R01 · FY2024 · NS · contact PI
Sodium channel mutations as a possible cause for primary dysautonomia$530,798
R01 · FY2023 · NS · contact PI
Developing a CLIA compliant LDT for detecting plasma piR-Ls/pfeRNAs to distinguish benign and malignant lung nodules$331,594
UH3 · FY2021 · CA · contact PI
Developing a CLIA compliant LDT for detecting plasma piR-Ls/pfeRNAs to distinguish benign and malignant lung nodules$331,594
UH3 · FY2020 · CA · contact PI
Developing a CLIA compliant LDT for detecting plasma piR-Ls/pfeRNAs to distinguish benign and malignant lung nodules$331,594
UH3 · FY2019 · CA · contact PI
Screening for Lung Cancer in the HIV Patient$140,130
K23 · FY2007 · CA · contact PI
SCREENING FOR LUNG CANCER IN THE HIV PATIENT$68,171
M01 · FY2007 · RR · contact PI
Screening for Lung Cancer in the HIV Patient$140,130
K23 · FY2006 · CA · contact PI
Screening for Lung Cancer in the HIV Patient$139,250
K23 · FY2005 · CA